Skip to main content

and
  1. Article

    Open Access

    Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate

    Only limited information is available on cost efficacy of the various biological agents used to treat patients with rheumatoid arthritis with intolerance or for whom it would be inappropriate to continue treat...

    Alberto Batticciotto, Roberto Ravasio, Marta Riva in Advances in Therapy (2016)